Sodium Chloride Symporter Inhibitors
"Sodium Chloride Symporter Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.
| Descriptor ID |
D049993
|
| MeSH Number(s) |
D27.505.519.562.812 D27.505.696.560.500.863
|
| Concept/Terms |
Diuretics, Thiazide- Diuretics, Thiazide
- Thiazide Diuretics
- Benzothiadiazine Diuretics
- Diuretics, Benzothiadiazine
|
Below are MeSH descriptors whose meaning is more general than "Sodium Chloride Symporter Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Sodium Chloride Symporter Inhibitors".
This graph shows the total number of publications written about "Sodium Chloride Symporter Inhibitors" by people in this website by year, and whether "Sodium Chloride Symporter Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sodium Chloride Symporter Inhibitors" by people in Profiles.
-
Maio V, Gagne JJ. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2010 Feb; 35(1):55-61.
-
Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003 Dec 03; 290(21):2805-16.
-
Stein MS, Flicker L, Scherer SC, Paton LM, O'Brien ML, Walton SC, Chick P, Di Carlantonio M, Zajac JD, Wark JD. Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf). 2001 May; 54(5):583-92.
-
Zyczynski TM, Leidy NK, Kong BW, Helaszek CT, Michelson EL. Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial. Heart Dis. 2000 Nov-Dec; 2(6):400-6.
-
Skolnik NS, Beck JD, Clark M. Combination antihypertensive drugs: recommendations for use. Am Fam Physician. 2000 May 15; 61(10):3049-56.
-
Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1999 Aug 01; 84(3):289-93.